Patrícia Susana Correia Lopes Barreto (2313-D0C8-C843)

Curriculum Vitae

Patrícia Barreto

Patrícia Barreto concluiu a Licenciatura em Ciências Farmacêuticas em 2005 pela Faculdade de Farmácia da Universidade de Coimbra, o Mestrado em Saúde Pública em 2016 pela Faculdade de Medicina da Universidade de Coimbra e frequenta o Programa de Doutoramento em Ciências da Saúde pela Faculdade de Medicina da Universidade de Coimbra desde 2018. É Subdiretora e Farmacêutica no do Centro de Ensaios Clínicos da Associação para a Investigação Biomédica e Inovação em Luz e Imagem (AIBILI). É membro do Grupo de Interesse em Ensaios Clínicos da Ordem dos Farmacêuticos. Publicou 26 artigos em revistas especializadas em Q1 e Q2, com revisão por pares, e participou como oradora em diversos congressos nacionais e internacionais. Foi membro da equipa de investigação em 43 ensaios clínicos, e participou em como membro da equipa de investigação em 14 projectos. Colabora anualmente com a Escola Superior de Saúde do Instituto Politécnico do Porto, na licenciatura em Ortóptica, com a Faculdade de Farmácia da Universidade de Coimbra, na licenciatura em Ciências Farmacêuticas e no Mestrado em Farmacologia Aplicada, e com a Faculdade de Medicina da Universidade de Coimbra, no Mestrado em Investigação Biomédica.

Read full resume ↓

Identification

Personal identification

Full name: Patrícia Susana Correia Lopes Barreto

Citation names

Barreto, Patrícia

Author identifiers

Ciência ID: 2313-D0C8-C843
ORCID iD: 0000-0002-3375-551X

Email addresses

pbarreto@aibili.pt (Professional)
patricia.s.barreto@gmail.com (Personal)

Addresses

AIBILI - Associação para a Investigação Biomédica e Inovação em Luz e Imagem. Edifício Prof. Doutor José Cunha-Vaz. Azinhaga de Santa Comba, Celas, 3000-548, Coimbra, Coimbra, Portugal (Professional)

Knowledge fields

Medical and Health Sciences - Health Sciences

Languages

Language	Speaking	Reading	Writing	Listening
Portuguese (Mother tongue)
English	Proficiency (C2)	Proficiency (C2)	Proficiency (C2)	Proficiency (C2)
Spanish; Castilian	Intermediate (B1)	Intermediate (B1)	Beginner (A1)	Intermediate (B1)

Education

	Degree	Classification
2014 - 2024 Concluded	ICH E6 Good Clinical Practice (Outros) Infonetica Ltd, United Kingdom
2022/07 Concluded	EudraVigilance for the electronic transmission of Individual Case Safety Reports (ICSRs) (Outros) European Medicines Agency, Netherlands
2022/06 Concluded	Extended EudraVigilance Medicinal Product Dictionary (Outros) European Medicines Agency, Netherlands
2018/09 - 2022 Ongoing	Programa de Doutoramento em Ciências da Saúde (Doutoramento) Major in Ciências Biomédicas Universidade de Coimbra Faculdade de Medicina, Portugal "Age-Related Macular Degeneration: Genetic Susceptibility, Nutrition and Lifestyle" (THESIS/DISSERTATION)
2016 Concluded	Mestrado em Saúde Pública (Mestrado) Universidade de Coimbra Faculdade de Medicina, Portugal "Padrão Alimentar, Nutricional e Estilos de Vida Relacionados com a Degenerescência Macular Relacionada com a Idade na População Portuguesa" (THESIS/DISSERTATION)
1999 - 2005 Concluded	Ciências Farmacêuticas (Licenciatura) Universidade de Coimbra Faculdade de Farmácia, Portugal

Affiliation

Teaching in Higher Education

	Category Host institution	Employer
2017/09 - 2020/07	Invited Assistant (Polytechnic Teacher)	Instituto Politécnico do Porto, Portugal
	Instituto Politécnico do Porto Escola Superior de Saúde, Portugal

Others

	Category Host institution	Employer
2024/10 - Current	Subdiretora Centro de Ensaios Clínicos/Farmacêutica	Associação para a Investigação Biomédica e Inovação em Luz e Imagem, Portugal
	Associação para a Investigação Biomédica e Inovação em Luz e Imagem, Portugal
2013/12/01 - 2024/10	Assistente de Direção Centro de Ensaios Clínicos/Farmacêutica	Associação para a Investigação Biomédica e Inovação em Luz e Imagem, Portugal
	Associação para a Investigação Biomédica e Inovação em Luz e Imagem, Portugal
2010/07/01 - 2013/07/01	Project Leader	Novexem Portugal, Portugal

2009/01/01 - 2013/07/01	Clinical Research Associate	Novexem Portugal, Portugal

2005/07/01 - 2008/12/31	Farmacêutica	Farmácia Loureiro, Portugal
	Farmácia Loureiro, Portugal

Projects

Contract

	Designation	Funders
2022 - Current	Exploratory project – Diabetic Retinopathy: from clinical to cellular phenotyping (C2C) CEC-012-22 Team member	Associação para a Investigação Biomédica e Inovação em Luz e Imagem iCBR - Coimbra Institute for Clinical and Biomedical Research Ongoing
2020 - Current	Retinal and cognitive dysfunction in type 2 diabetes: unravelling the common pathways and identification of patients at risk of dementia (RECOGNISED) ECR-RET-2019-14 NCT04281186 Team member	European Union Ongoing
2018 - Current	Development of novel clinical endpoints for interventional clinical trials with a regulatory and patient access intention in patients with intermediate age-related macular degeneration (MACUSTAR) ECR-AMD-2017-13 NCT03349801 Team member	European Union European Federation of Pharmaceutical Industries and Associations Ongoing
2016/04 - Current	STAR- Development of a Model for Advanced Screening for Timely Treatment of Age-Related Eye Diseases CEC/008/2016 / STAR Project Coordinator	Associação para a Investigação Biomédica e Inovação em Luz e Imagem Ongoing
2015 - Current	Characterization of potential biomarkers of Eye Disease and Vision Loss (EYEMARKER) 4C-2015-08 NCT02500862 Team member	Associação para a Investigação Biomédica e Inovação em Luz e Imagem Ongoing
2022 - 2025	Diet, medication, and lifestyle in Age-related Macular Degeneration: can the genetic expression be modulated? (AMD LifeGene) 4C-2022-11 NCT05735730 Researcher	EURETINA - The European Society of Retina Specialists Concluded
2021 - 2024	10-year Progression of Diabetic Retinopathy. Identification of Signs and Surrogate Outcomes (PROGRESS 10) CEC/011/20 NCT04650165 Team member	Concluded
2021 - 2022	Metabolomics: A Novel Tool for Investigating the Pathogenesis of Age-related Macular Degeneration (AMDMetab) CEC/010/20 NCT04241536 Team member	EURETINA - The European Society of Retina Specialists Concluded
2018/07/01 - 2021/12/31	CORDIS - Characterization of retinal vascular disease in eyes with mild to moderate non-proliferative diabetic retinopathy in Diabetes type 2, using novel non-invasive imaging methods, in a longitudinal and prospective clinical study with 2 years of duration. PTDC/MEC-OFT/30375/2017 NCT03696810 Protocol CEC/194/18 ClinicalTrials.gov Identifier: NCT03696810 Team member Associação para a Investigação Biomédica e Inovação em Luz e Imagem, Portugal	Fundação para a Ciência e a Tecnologia Concluded
2017 - 2019	Progression of Diabetic Retinopathy. Identification of Signs and Surrogate Outcomes (PROGRESS) CEC/007/2016 NCT03010397 Team member	Associação para a Investigação Biomédica e Inovação em Luz e Imagem Concluded
2016 - 2017	Five-year incidence of Age-related Macular Degeneration in the central region of Portugal (AMD Incidence) Protocol number: 4C-2016-09 NCT02748824 Team member	Concluded
2013 - 2017	VitaminD3 –Omega3 –Home Exercise –HeALTHy Ageing and Longevity Randomized, double-blind, placebo-controlled, multi-centre clinical trial (Do-Health) Do-Health Pharmacist at the centre (Faculty of Medicine, University of Coimbra)	European Commission Seventh Framework Programme for Research and Technological Development Concluded
2015 - 2016	Metabolomics, Genetics and Environment – a novel integrative approach to Age-Related Macular Degeneration IN0654 Membro da equipa Fundação para a Ciência e a Tecnologia, Portugal	Concluded
2015 - 2015	Genotypic and Phenotypic characterization of retinal angiomatous proliferation (RAP) lesions Protocol number: CEC 006/2015 Membro da equipa	Associação para a Investigação Biomédica e Inovação em Luz e Imagem Concluded

Other

	Designation	Funders
2024 - Current	A phase III, randomized, double-masked, placebo-controlled, multicenter study to evaluate the efficacy, safety, pharmacokinetics, and pharmacodynamics of satralizumab in participantswith moderate-to-severe thyroid eye disease (SATRA-GO2) Protocol number: GP44729 NCT06106828 Pharmacist at the Clinical Trials Centre of AIBILI	F Hoffmann-La Roche AG Ongoing
2024 - Current	A phase III, multicenter, randomized, double-masked, sham-controlled study to investigate the efficacy, safety, pharmacokinetics, and pharmacodynamics of RO7200220 administered intravitreally in patients with uveitic macular edema (SANDCAT) Protocol number: GR44278 NCT05642325 Pharmacist at the Clinical Trials Centre of AIBILI	F Hoffmann-La Roche AG Ongoing
2024 - Current	A Randomized, Double-masked, Multi-center, 3-Arm Pivotal Phase 2/3 Study to Evaluate the Efficacy and Safety of Intravitreal EYE103 Compared with Intravitreal ranibizumab (0.5mg) in Participants with Diabetic Macular Edema (BRUNELLO) Protocol number: EYE-RES-102 NCT06571045 Pharmacist at the Clinical Trials Centre of AIBILI	EyeBiotech Ltd.
2023 - Current	A phase III, multicenter, randomized, double-masked, sham-controlled study to investigate the efficacy, safety, pharmacokinetics, and pharmacodynamics of RO7200220 administered intravitreally in patients with uveitic macular edema (MEERKAT) Protocol number: GR44277 NCT05642312 Farmacêutico responsável no centro de ensaios clínicos da AIBILI	F Hoffmann-La Roche AG Ongoing
2023 - Current	Randomized, Double-Masked, Active-Controlled, Phase 3 Study of the Efficacy and Safety of Aflibercept 8 mg in Macular Edema Secondary to Retinal Vein Occlusion (QUASAR) Protocol number: 22153 NCT05850520 Pharmacist at the Clinical Trials Centre of AIBILI	Bayer Pharma AG Forschung und Entwicklung Ongoing
2020 - Current	A Multicenter, Open-Label Extension Study to Evaluate the Long-Term Safety and Tolerability of Faricimab In Patients with Diabetic Macular Edema (RHONE-X) Protocol number: GR41987 NCT04432831 Pharmacist at the Clinical Trials Centre of AIBILI	F Hoffmann-La Roche AG Concluded
2022 - 2024	A Phase 2 randomized, placebo-controlled, double-masked proof-of-concept and dose-finding study to investigate the efficacy and safety of runcaciguat (BAY 1101042) in patients with moderately severe to severe non-proliferative diabetic retinopathy (NEON) Protocol number: 20739 NCT04722991 Pharmacist at the Clinical Trials Centre of AIBILI	Bayer Pharma AG Forschung und Entwicklung Concluded
2021 - 2023	A 52-week multicenter, randomized, double-masked, 2-arm parallel study to compare efficacy, safety and immunogenicity of SOK583A1 to Eylea®, administered intravitreally, in patients with neovascular age-related macular degeneration (MYLIGHT) Protocol number: CSOK583A1201 NCT04864834 Pharmacist at the Clinical Trials Centre of AIBILI	Hexal AG
2019 - 2022	A phase III, multicentre, randomized, double-masked, active comparator-controlled study to evaluate the efficacy and safety of RO6867461 in patients with diabetic macular edema (RHINE) Protocol number: GR40398 NCT03622593 Pharmacist at the Clinical Trials Centre of AIBILI	F Hoffmann-La Roche AG Concluded
2019 - 2022	A two-year, three-arm, randomized, double-masked, multicentre, phase III study assessing the efficacy and safety of brolucizumab versus aflibercept in adult patients with visual impairment due to diabetic macular edema (KESTREL) Protocol number: CRTH258B2301 NCT03481634 Pharmacist at the Clinical Trials Centre of AIBILI	Novartis AG Concluded
2019 - 2022	A Multicenter, Double-Masked, Randomized, Dose-Ranging Trial to Evaluate the Efficacy andSafety of Conbercept Intravitreal Injection in Subjects with Neovascular Age-related Macular Subjects with Neovascular Age-related Macular Degeneration (PANDA) Protocol number: KHB-1801 NCT03577899 Pharmacist at the Clinical Trials Centre of AIBILI	Chengdu Kanghong Pharmaceuticals Group Co Ltd Cancelled
2019 - 2020	Randomized,double-masked,placebo-controlled study to evaluate safety,tolerability,pharmacodynamics and pharmacokinetics of oral BI 1467335 for 12 weeks with a 12 week follow up period in patients with non-proliferative diabetic retinopathy without center-involved diabetic macular edema (ROBIN) Protocol number: BI 1386-0012 NCT03238963 Pharmacist at the Clinical Trials Centre of AIBILI	Boehringer Ingelheim Europe GmbH Concluded
2016 - 2018	A Two-Year, Randomized, Double-Masked, Multicenter, Two-Arm Study Comparing the Efficacy and Safety of RTH258 6 mg Versus Aflibercept in Subjects with Neovascular Age-Related Macular Degeneration (HARRIER) Protocol number: RTH258-C002 NCT02434328 Pharmacist at the Clinical Trials Centre of AIBILI	Alcon Switzerland SA Concluded
2016 - 2018	An open-label, randomized, active-controlled, parallel-group, Phase-3b study of the efficacy, safety, and tolerability of three different treatment regimens of 2 mg aflibercept administered by intravitreal injections to subjects with diabetic macular edema (VIOLET) Protocol number: 17613 NCT02818998 Pharmacist at the Clinical Trials Centre of AIBILI	Bayer SA Concluded
2016 - 2018	Efficacy and safety of Eslicarbazepine acetate (BIA 2-093) as monotheraphy for patients with newly diagnosed partial-onset seizures: a double- blind, double-dummy, randomized, active-controlled, parallel- group, multicenter clinical study. Open-Label ESL Extension Código do protocolo: BIA-2093-311/EXT NCT02484001 Pharmacist at the Clinical Trials Centre of AIBILI	Laboratórios Bial Concluded
2015 - 2018	A phase III, multicenter, randomized, double-masked, sham-controlled study to assess the efficacy and safety of lampalizumab administeredintravitreally to patients with geographic atrophy secondary to age-related macular degeneration (SPECTRI) Protocol number: GX29185 NCT02247531 Pharmacist at the Clinical Trials Centre of AIBILI	F Hoffmann-La Roche AG Concluded
2015 - 2018	A Randomized, Double-masked, Sham-controlled Phase 4 Study of the Efficacy, Safety, and Tolerability of Intravitreal Aflibercept Monotherapy Compared to Aflibercept with Adjunctive Photodynamic Therapy in patients with Polypoidal Choroidal Vasculopathy (ATLANTIC) Protocol number: ECR-AMD-2015-09 NCT02495181 Pharmacist at the Clinical Trials Centre of AIBILI	Associação para a Investigação Biomédica e Inovação em Luz e Imagem Bayer SA Concluded
2016 - 2017	A randomized, double-masked, placebo-controlled exploratory study to evaluate pharmacodynamics, safety and tolerability of orally administered BI 1026706 for 12 weeks in patients with mild visual impairment due to center-involved diabetic macular edema BI 1320.22 NCT02732951 Pharmacist at the Clinical Trials Centre of AIBILI	Boehringer Ingelheim AB Concluded
2015 - 2017	Estudo de intervenção em humanos, multicêntrico e aleatorizado, de suplementação nutricional em doentes com DMRI húmida unilateral (RETILUT) Protocol number: THEA-UNAV1/14 Pharmacist at the Clinical Trials Centre of AIBILI	Laboratoires Théa SAS Concluded
2015 - 2017	Open-label Phase-4 study to examine the change of vision-related quality of life in subjects with diabetic macular edema (DME) during treatment with intravitreal injections of 2 mg aflibercept according to EU the first year of treatmentlabel for the first year of treatment (AQUA) Protocol number: 17850 NCT02581995 Pharmacist at the Clinical Trials Centre of AIBILI	Bayer SA Concluded
2015 - 2017	An open-label, randomized, active-controlled, parallel-group, Phase-3b study of the efficacy, safety, and tolerability of 2 mg aflibercept administered by intravitreal injections using two different treatment regimens to subjects with neovascular age-related macular degeneration (nAMD) (AZURE) Protocol number: 16598 NCT02540954 Pharmacist at the Clinical Trials Centre of AIBILI	Bayer SA Concluded
2014 - 2017	A 12-month, phase IV, randomized, open label, multicenter study to compare efficacy of 0.5 mg ranibizumab PRN vs 2 mg aflibercept bimonthly intravitreal injections on retinal thickness stability till month 6 of treatment and explore functional outcomes up to month 12 in patients with CNV (SALT) CRFB002ADE23 NCT01958918 Pharmacist at the Clinical Trials Centre of AIBILI	Novartis AG Concluded
2014 - 2017	A phase 3 randomized, double-masked, controlled trial to establish the safety and efficacy of intravitreous anti PDGF-b pegylated aptamer in combination with avastin or eylea compared to avastin or eylea monotherapy in subjects with subfoveal neovascular AMD Protocol number: OPH1004 NCT01940887 Pharmacist at the Clinical Trials Centre of AIBILI	Ophthotech Corporation Concluded
2014 - 2016	Prospective, randomized, multicentre, open label, phase II/III study to assess efficacy and safety of ranibizumab 0.5 mg intravitreal injections plus panretinal photocoagulation vs PRP in monotherapy in the treatment of subjects with high risk proliferative diabetic retinopathy (PROTEUS) ECR-RET-2013-05 NCT01941329 Pharmacist at the Clinical Trials Centre of AIBILI	Associação para a Investigação Biomédica e Inovação em Luz e Imagem Concluded
2014 - 2016	Intraocular pressure and tolerability Study of Preservative Free Bimatoprost 0.03% Unit Dose or preservative free Latanoprost 0.005% Unit Dose in patients with ocular hypertension or glaucoma: a randomized, single masked, 3-month cross-over, Investigator-led, European multicenter Trial (SPORT) ECR-GLC-2013-06 NCT01975714 Pharmacist at the Clinical Trials Centre of AIBILI	Associação para a Investigação Biomédica e Inovação em Luz e Imagem Concluded
2013 - 2016	A multicenter,double-blind,double-dummy,follow-up study evaluating long-term safety of lacosamide (200 to 600mg/day) in comparison with carbamazepine (400 to 1200mg/day), used as monotherapy in subjects with partial-onset or generalized tonic-clonic seizures>16 years of age coming from SP0993 study Protocol number: SP0994 NCT01465997 Pharmacist at the Clinical Trials Centre of AIBILI	UCB Pharma AS Concluded
2013 - 2016	Efficacy and safety of Eslicarbazepine acetate (BIA 2-093) as monotheraphy for patients with newly diagnosed partial-onset seizures: a double- blind, double-dummy, randomized, active-controlled, parallel- group, multicenter clinical study Protocol number: BIA-2093-311 NCT02484001 Pharmacist at the Clinical Trials Centre of AIBILI	Laboratórios Bial Concluded
2014 - 2015	A non-randomised, open-label, multicenter phase 4 pilot study of the effect and safety of Iluvien® in chronic diabetic macular edema patients considered insufficiently responsive to available therapie with or without intravitreal corticosteroid therapy (RESPOND) 4C-2014-06 NCT02359526 Pharmacist at the Clinical Trials Centre of AIBILI	Associação para a Investigação Biomédica e Inovação em Luz e Imagem Concluded
2014 - 2015	A 12-month, phase IIIb, randomized, visual acuity assessor-masked, multicenter study assessing the efficacy and safety of ranibizumab 0.5mg in treat and extend regimen compared to monthly regimen, in patients with neovascular age-related macular degeneration (TREND) CRFB002A2411 NCT01948830 Pharmacist at the Clinical Trials Centre of AIBILI	Novartis International AG Concluded
2014 - 2015	Assessment of Anatomical and Functional Outcomes in Patients Treated with Ocriplasmin for Vitreomacular Traction/Symptomatic Vitreomacular Adhesion (JETREA) M-13-056 NCT02035748 Pharmacist at the Clinical Trials Centre of AIBILI	Alcon AG Concluded
2013 - 2015	Trial to Assess the Efficacy of Neuroprotective Drugs Administered Topically to Prevent or Arrest Diabetic Retinopathy (EUROCONDOR) Protocol number: 4C-2011-02 NCT01726075 Pharmacist at the Clinical Trials Centre of AIBILI	BCN Peptides Concluded
2013 - 2015	A randomised, double-masked, placebo-controlled study of the efficacy of gevokizumab in the treatment of patients with Behçet’s Disease Uveitis (EYEGUARD B) Protocol number: CL3-78989-002 NCT01965145 Pharmacist at the Clinical Trials Centre of AIBILI	Les Laboratoires Servier SAS Concluded
2013 - 2015	A randomized, double-masked, placebo-controlled study of the safety and efficacy of Gevokizumab in the treatment of active non-infectious intermediate, posterior, or pan- uveitis (EYEGUARD A) Protocol number: CL3-78989-005 NCT01684345 Pharmacist at the Clinical Trials Centre of AIBILI	Les Laboratoires Servier SAS Concluded
2013 - 2015	Efficacy and Safety of Ranibizumab With or Without Laser in Comparison to Laser in Branch Retinal Vein Occlusion (BRIGHTER) Protocol number: CRFB002E2402 NCT01599650 Pharmacist at the Clinical Trials Centre of AIBILI	Novartis AG Concluded
2013 - 2015	A 24-month, phase IIIb, randomized, double-masked, multicenter study assessing the efficacy and safety of two treatment regimens of 0.5 mg ranibizumab intravitreal injections guided by functional and/or anatomical criteria, in patients with neovascular age-related macular degeneration (OCTAVE) Protocol number: CRFB002A2405 NCT01780935 Pharmacist at the Clinical Trials Centre of AIBILI	Novartis International AG Concluded
2013 - 2015	A 12-month, randomized, double-masked, sham-controlled, multicenter study to evaluate the efficacy and safety of 0.5 mg ranibizumab intravitreal injections in patients with visual impairment due to vascular endothelial growth factor (VEGF) driven choroidal neovascularization (MINERVA) Protocol number: CRFB002G2301 NCT01840410 Pharmacist at the Clinical Trials Centre of AIBILI	Novartis Pharma AG Concluded
2013 - 2015	A Multi-Center, Open-Label Extension Study to Examine the Safety and Tolerability of ACP-103 in the Treatment of Psychosis in Parkinson’s Disease Protocol Number: ACP-103-015 NCT00658567 Pharmacist at the Clinical Trials Centre of AIBILI	Acadia Pharmaceuticals Inc Concluded
2013 - 2015	Efficacy and safety of 3 doses of S 38093 (2, 5 and 20 mg/day) versus placebo, in co-administration with donepezil (10 mg/day) in patients with moderate Alzheimer’s Disease. A 24-week international, multi-centre, randomised, double-blind,placebo-controlled phase IIb study Protocol number: CL2-38093-012 2011-005862-40 Pharmacist at the Clinical Trials Centre of AIBILI	Les Laboratoires Servier SAS Recherche & Développement Concluded
2013 - 2015	Multicenter,double-blind,randomized,controlled study comparing the efficacy/safety of lacosamide (200-600 mg/day) to controlled release carbamazepine (400-1200 mg/day), used as monotherapy in subjects newly/recently diagnosed with epilepsy with partial-onset or generalized tonic-clonic seizures Protocol Number: SP0993 NCT01243177 Pharmacist at the Clinical Trials Centre of AIBILI	UCB Pharma AS Concluded
2013 - 2015	A Randomized, Double-masked, placebo-controlled study of the Safety and Efficacy of Gevokizumab in the treatment of subjects with non-infectious intermediate, posterior, or pan- uveitis currently controlled with systemic treatment (EYEGUARD C) Protocol number: CL3-78989-006 NCT01747538 Pharmacist at the Clinical Trials Centre of AIBILI	Les Laboratoires Servier SAS Concluded
2013 - 2015	Efficacy and safety of BIA 9-1067 in idiopathic Parkinson’s disease patients with “wearing-off” phenomenon treated with levodopa plus a dopa decarboxylase inhibitor:double-blind,randomised,placebo-and active-controlled,parallel-group,multicentre study (BIPARK II) Protocol number: BIA-91067-302 NCT01568073 Pharmacist at the Clinical Trials Centre of AIBILI	Laboratórios Bial Concluded
2013 - 2014	Ranibizumab Intravitreal Injections in Patients With Visual Impairment Due to Macular Edema Secondary to Central Retinal Vein Occlusion (CRYSTAL) Protocol number: CRFB002E2401 NCT01535261 Pharmacist at the Clinical Trials Centre of AIBILI	Novartis AG Concluded
2013 - 2014	Multicenter, randomized, double-masked, 3 arms, vehicle controlled, 4-month phase 3 trial with a 8 month safety follow up period to evaluate the efficacy and safety of 2 dosing regimen of NOVA22007 1mg/ml eye drops, administered 4 times/day in pediatric patients with active severe vernal (VEKTIS) Protocol number: NVG09B113 NCT01751126 Pharmacist at the Clinical Trials Centre of AIBILI	Santen SA Concluded

Outputs

Publications

Journal article	Barreto, Patrícia; Farinha, Claudia; Coimbra, Rita; Silva, Rufino. "Author Response: Unveiling Statins and Genetics in Age-Related Macular Degeneration Progression: What Is the Appropriate Modeling Strategy?". Investigative Ophthalmology & Visual Science 66 3 (2025): 3. Published • 10.1167/iovs.66.3.3 Figueiredo, Inês; Farinha, Cláudia; Barreto, Patrícia; Coimbra, Rita; Pereira, Pedro; Marques, João Pedro; Pires, Isabel; Cachulo, Maria Luz; Silva, Rufino. "Nutritional Genomics: Implications for Age-Related Macular Degeneration". Nutrients 16 23 (2024): 4124. Published • 10.3390/nu16234124 Barreto, Patrícia; Farinha, Cláudia; Coimbra, Rita; Cachulo, Maria Luz; Melo, Joana Barbosa; Lechanteur, Yara; Hoyng, Carel B.; Cunha-Vaz, José; Silva, Rufino. "Unveiling Statins and Genetics in Age-Related Macular Degeneration: The Coimbra Eye Study—Report 9". Investigative Ophthalmology & Visual Science 65 6 (2024): 38. Published • 10.1167/iovs.65.6.38 Farinha, Cláudia; Barreto, Patrícia; Coimbra, Rita; Machado, Maria Beatriz; Figueiredo, Inês; Cachulo, Maria Luz; Cunha-Vaz, José; Silva, Rufino. "Age-Related Macular Degeneration and Extramacular Drusen: Genetic Associations in the Coimbra Eye Study". Investigative Ophthalmology & Visual Science 65 5 (2024): 35. Published • 10.1167/iovs.65.5.35 Vergroesen, Joëlle E.; Schuster, Alexander K.; Stuart, Kelsey V.; Asefa, Nigus G.; Cougnard-Grégoire, Audrey; Delcourt, Cécile; Schweitzer, Cédric; et al. "Association of Systemic Medication Use with Glaucoma and Intraocular Pressure". Ophthalmology 130 9 (2023): 893-906. Published • 10.1016/j.ophtha.2023.05.001 Barreto, Patrícia; Farinha, Cláudia; Coimbra, Rita; Cachulo, Maria Luz; Melo, Joana Barbosa; Lechanteur, Yara; Hoyng, Carel B.; Cunha-Vaz, José; Silva, Rufino. "Interaction between genetics and the adherence to the Mediterranean diet: the risk for age-related macular degeneration. Coimbra Eye Study Report 8". Eye and Vision 10 1 (2023): Published • 10.1186/s40662-023-00355-0 Barreto, Patrícia; Claudia Farinha; Rita Coimbra; Maria Luz Cachulo; Joana Barbosa Melo; Carel B. Hoyng; José Cunha-Vaz; Rufino Silva. "Genética e Dieta Mediterrânica: Qual o Risco para a Degenerescência Macular da Idade?". Oftalmologia 47 1 (2023): 33-40. Published Mauschitz, Matthias M; Verzijden, Timo; Schuster, Alexander K; Elbaz, Hisham; Pfeiffer, Norbert; Khawaja, Anthony; Luben, Robert N; et al. "Association of lipid-lowering drugs and antidiabetic drugs with age-related macular degeneration: a meta-analysis in Europeans". British Journal of Ophthalmology 107 12 (2022): 1880-1886. Published • 10.1136/bjo-2022-321985 Farinha, Cláudia; Barreto, Patrícia; Coimbra, Rita; Cachulo, Maria Luz; Melo, Joana Barbosa; Cunha-Vaz, José; Lechanteur, Yara; Hoyng, Carel B.; Silva, Rufino. "Common and rare genetic risk variants in age-related macular degeneration and genetic risk score in the Coimbra eye study". Acta Ophthalmologica 101 2 (2022): 185-199. Published • 10.1111/aos.15232 Farinha, Cláudia; Barreto, Patrícia; Coimbra, Rita; Iutis, Adela; Cachulo, Maria Luz; Cunha-Vaz, José; Lechanteur, Yara T. E.; Hoyng, Carel B.; Silva, Rufino. "Phenotypic Expression of CFH Rare Variants in Age-Related Macular Degeneration Patients in the Coimbra Eye Study". Investigative Opthalmology & Visual Science 63 9 (2022): 5. Published • 10.1167/iovs.63.9.5 Amorim, Madania; Martins, Beatriz; Caramelo, Francisco; Gonçalves, Conceição; Trindade, Grimalde; Simão, Jorge; Barreto, Patrícia; et al. "Putative Biomarkers in Tears for Diabetic Retinopathy Diagnosis". Frontiers in Medicine 9 (2022): Published • 10.3389/fmed.2022.873483 Lains, Ines; Mendez, Kevin M.; Gil, João Q.; Miller, John B.; Kelly, Rachel S.; Barreto, Patrícia; Kim, Ivana K.; et al. "Urinary Mass Spectrometry Profiles in Age-Related Macular Degeneration". Journal of Clinical Medicine 11 4 (2022): 940. Published • 10.3390/jcm11040940 Claudia Farinha; Barreto, Patrícia; Rita Coimbra; Maria Luz Cachulo; Joana Barbosa Melo; Carel B. Hoyng; Joaquim Murta. "Associações Genéticas e Genetic Risk Score na Degenerescência Macular da Idade no Estudo Epidemiológico de Coimbra". Oftalmologia 46 1 (2022): 33-42. Published Ribeiro, Luísa; Marques, Inês P.; Coimbra, Rita; Santos, Torcato; Madeira, Maria H.; Santos, Ana Rita; Barreto, Patrícia; Lobo, Conceição; Cunha-Vaz, José. "Characterization of One-Year Progression of Risk Phenotypes of Diabetic Retinopathy". Ophthalmology and Therapy 11 1 (2021): 333-345. Published • 10.1007/s40123-021-00437-z Silva, Rufino; Arias, Luis; Nunes, Sandrina; Farinha, Claudia; Coimbra, Rita; Marques, João P.; Cachulo, Maria L.; et al. "Efficacy and Safety of Intravitreal Aflibercept Treat and Extend for Polypoidal Choroidal Vasculopathy in the ATLANTIC Study: A Randomized Clinical Trial". Ophthalmologica 245 1 (2021): 80-90. Published • 10.1159/000518235 Sandrina Nunes; Rita Coimbra; Barreto, Patrícia; João Rodrigues; Carlos Almeida; Miguel Raimundo; Sónia Simões; et al. "Nutritional Patterns using Principal Component Analysis and Their Associations with Age-Related Macular Degeneration. The Coimbra Eye Study – Report 7. Nutritional Patterns using PCA and AMD". Journal of Statistics on Health Decision 2 2 (2020): 52-57. Published Jordan-Yu, Janice Marie; Teo, Kelvin; Fan, Qiao; Gana, Jose Carlos; Leopando, Anna Karina; Nunes, Sandrina; Farinha, Cláudia; et al. "T and genetic variations between Asian and Caucasian polypoidal choroidal vasculopathy". British Journal of Ophthalmology 105 12 (2020): 1716-1723. Published • 10.1136/bjophthalmol-2020-317537 Farinha, Cláudia; Cachulo, Maria Luz; Coimbra, Rita; Alves, Dalila; Nunes, Sandrina; Pires, Isabel; Marques, João Pedro; et al. "Age-Related Macular Degeneration Staging by Color Fundus Photography vs. Multimodal Imaging—Epidemiological Implications (The Coimbra Eye Study—Report 6)". Journal of Clinical Medicine 9 5 (2020): 1329. Published • 10.3390/jcm9051329 Roh, Miin; Shin, Hyun Joon; Laíns, Inês; Providência, Joana; Caseiro-Alves, Maria; Barreto, Patrícia; Vavvas, Demetrios G.; et al. "Higher Intake of Polyunsaturated Fatty Acid and Monounsaturated Fatty Acid is Inversely Associated With AMD". Investigative Opthalmology & Visual Science 61 2 (2020): 20. Published • 10.1167/iovs.61.2.20 Laíns, Inês; Chung, Wonil; Kelly, Rachel S.; Gil, João; Marques, Marco; Barreto, Patrícia; Murta, Joaquim N.; et al. "Human Plasma Metabolomics in Age-Related Macular Degeneration: Meta-Analysis of Two Cohorts". Metabolites 9 7 (2019): 127. Published • 10.3390/metabo9070127 Laíns, Inês; Duarte, Daniela; Barros, António S.; Martins, Ana Sofia; Carneiro, Tatiana J.; Gil, João Q.; Miller, John B.; et al. "Urine Nuclear Magnetic Resonance (NMR) Metabolomics in Age-Related Macular Degeneration". Journal of Proteome Research 18 3 (2019): 1278-1288. 10.1021/acs.jproteome.8b00877 Farinha, Cláudia Virgínia Louro; Cachulo, Maria Luz; Alves, Dalila; Pires, Isabel; Marques, João Pedro; Barreto, Patrícia; Nunes, Sandrina; et al. "Incidence of Age-Related Macular Degeneration in the Central Region of Portugal: The Coimbra Eye Study – Report 5". Ophthalmic Research 61 4 (2019): 226-235. 10.1159/000496393 Martins, Amélia; Farinha, Cláudia; Raimundo, Miguel; Lopes, Marta; Santos, Ana Rita; Melo, Pedro; Marques, Marco; et al. "Multimodal Evaluation of the Fellow Eye of Patients with Retinal Angiomatous Proliferation". Ophthalmic Research 59 2 (2018): 88-97. Published • 10.1159/000481262 Raimundo, Miguel; Mira, Filipe; Cachulo, Maria da Luz; Barreto, Patrícia; Ribeiro, Luísa; Farinha, Cláudia; Laíns, Inês; et al. "Adherence to a Mediterranean diet, lifestyle and age-related macular degeneration: the Coimbra Eye Study - Report 3". Acta Ophthalmologica 96 8 (2018): e926-e932. Published • 10.1111/aos.13775 Nunes, Sandrina; Alves, Dalila; Barreto, Patrícia; Raimundo, Miguel; da Luz Cachulo, Maria; Farinha, Cláudia; Laíns, Inês; et al. "Adherence to a Mediterranean diet and its association with age-related macular degeneration. The Coimbra Eye Study–Report 4". Nutrition 51-52 (2018): 6-12. Published • 10.1016/j.nut.2017.12.010 Laíns, Inês; Wang, Jay; Providência, Joana; Mach, Steven; Gil, Pedro; Gil, João; Marques, Marco; et al. "Choroidal Changes Associated With Subretinal Drusenoid Deposits in Age-related Macular Degeneration Using Swept-source Optical Coherence Tomography". American Journal of Ophthalmology 180 (2017): 55-63. Published • 10.1016/j.ajo.2017.05.021
Online resource	Barreto, Patrícia. Interação entre o risco genético para a Degenerescência Macular da Idade e a adesão à dieta Mediterrânica no risco para a doença. 2023. https://saudeonline.pt/tag/patricia-barreto/.
Thesis / Dissertation	Barreto, Patrícia. "Padrão alimentar, nutricional e estilos de vida relacionados com a degenerescência macular relacionada com a idade na população portuguesa". Master, Universidade de Coimbra Faculdade de Medicina, 2016.

Activities

Oral presentation

	Presentation title	Event name Host (Event location)
2024/11/22	Uncovering statins and genetics in age-related macular degeneration	Congresso Nacional dos Farmacêuticos 2024 Ordem dos farmacêuticos (Lisboa, Portugal)
2024/11/05	Ensaios clínicos da iniciativa do investigador e AIBILI: um caso de sucesso	O Farmacêutico e os ensaios clínicos; novas perspectivas Ordem dos Farmacêuticos
2024/09/19	Lifestyle, genetic risk and age-related macular degeneration – The Coimbra Eye Study	24 th EURETINA Congress 2024 EURETINA (Barcelona, Spain)
2024/07/10	Genetics & statins in the progression for age-related macular degeneration	IV Reunião dos Grupos de Investigação da AIBILI AIBILI (Coimbra, Portugal)
2024/05/07	Uncovering statins with genetics in age-related macular degeneration	ARVO 2024 ARVO (Seattle, United States)
2024/05/07	Association between the genetic risk score and extramacular drusen in an age-related macular degeneration cohort - The Coimbra Eye Study	ARVO 2024 ARVO (Seattle, United States)
2023/12/01	Statins and genetics in the risk of progression of age-related macular degeneration. The Coimbra Eye Study	66º Congresso Português de Oftalmologia Sociedade Portuguesa de Oftalmologia (Vilamoura, Portugal)
2023/10/07	Statins and genetics in the risk of progression of age-related macular degeneration - The Coimbra Eye Study	23 rd EURETINA Congress 2023 EURETINA (Amesterdão, Netherlands)
2023/05/24	Age-related macular degeneration: the interaction of genetics, Mediterranean diet and statins	III reunião dos Grupos de Investigação da AIBILI AIBILI (Coimbra, Portugal)
2022/12/01	Genetics and the Mediterranean diet: what is the risk for age-related macular degeneration?	65º Congresso Português de Oftalmologia Sociedade Portuguesa de Oftalmologia (Coimbra, Portugal)
2022/09/03	Association of genetics and the adherence to the mediterranean diet: the risk for age-related macular degeneration	22 nd EURETINA Congress 2022 EURETINA (Hamburgo, Germany)
2022/07/20	Cluster Analysis and Genetic Risk Score in Age-related Macular Degeneration - The Coimbra Eye Study	The 17th Conference of the International Federation of Classification Societies (Porto, Portugal)
2022/05/11	Association of genetics and the adherence to the Mediterranean diet: the risk for age-related macular degeneration	ARVO 2022
2021/05	Genetic characterization of a Portuguese age-related macular degeneration population	ARVO 2021 Association for Research in Vision and Ophthalmology (San Francisco & on line, United States)
2021/05	Characterization of risk phenotypes of type 2 diabetes nonproliferative retinopathy	ARVO 2021 Association for Research in Vision and Ophthalmology (San Francisco & online, United States)
2021/05	Characterization of one-year progression in risk phenotypes of diabetic retinopathy	ARVO 2021 Association for Research in Vision and Ophthalmology (San Francisco & online, United States)
2021/05	Common and rare genetic risk variants for Age-related Macular Degeneration progression in the Coimbra Eye Study.	ARVO 2021 Association for Research in Vision and Ophthalmology (São Francisco & Online, United States)
2020/07/10	Surgimento das Boas Práticas Clínicas	Workshop em Boas Práticas Clínicas \| Formato webinar AIBILI
2019/12/06	Age-related macular degeneration prevalence and staging by color fundus photography vs multimodal imaging. The Coimbra Eye Study	62.º Congresso Português de Oftalmologia SPO (Portugal)
2019/12	Estudo CORDIS - um ensaio longitudinal, prospetivo e intervencional numa população de doentes diabéticos tipo 2 com retinopatia ligeira a moderada	Sociedade Portuguesa de Oftalmologia - SPO SPO (Portugal)
2018/03	Estudo sobre a incidência da Degenerescência Macular Relacionada com a Idade aos cinco anos na região centro de Portugal.	XIX Congresso Nacional de Ortoptistas Associação Portuguesa de Ortoptistas (Espinho, Portugal)
2017/09	Food and Nutritional Pattern and Lifestyle related to Age-Related Macular Degeneration in Portugal.	17 th EURETINA Congress 2017 EURETINA (Barcelona, Spain)
2017/09	Multimodal evaluation of the fellow eye of patients with retinal angiomatous proliferation	17 th EURETINA Congress 2017 EURETINA (Barcelona, Spain)
2016/12	Age-related Macular Degeneration: an association with physical activity and lifestyle	59º Congresso Português e Oftalmologia Sociedade Portuguesa de Oftalmologia (Coimbra, Portugal)
2016/12	Espessura da coróide na Degenerescência Macular relacionada com a Idade: a influência dos drusens reticulares.	59º Congresso Português e Oftalmologia Sociedade Portuguesa de Oftalmologia (Coimbra, Portugal)
2016/12	Terapêutica no Edema Macular Diabético. Que Futuro?	59º Congresso Português e Oftalmologia Sociedade Portuguesa de Oftalmologia (Coimbra, Portugal)
2016/11/09	CEC - Clinical Trials Centre - AIBILI Clinical Trials in Ophthalmology	Conferência APIFARMA 2016 "Investigação Clínica - Do Compromisso à Acção APIFARMA (Lisboa, Portugal)
2016/10	The Role of Adherence to a Mediterranean Diet and Lifestyle Risk Factors in AMD - The Coimbra Eye Study.	American Academy of Ophthamology American Academy of Ophthamology (Chicago, United States)
2016/10	The Role of Reticular Pseudodrusen on Choroidal Thickness With Swept Source OCT	American Academy of Ophthamology; American Academy of Ophthamology; (Chicago, United States)
2008/05	Mental Health	10th Congress of Young Pharmacists (Opava, Czech Republic)
2008/05	Pharmaceutical Education in Portugal	10th Congress of Young Pharmacists (Opava, Czech Republic)

Event organisation

	Event name Type of event (Role)	Institution / Organization
2023/06/01 - 2023/06/03	33 rd EAsDEC Conference 2023 (2023/06/01 - 2023/06/03)	Associação para a Investigação Biomédica e Inovação em Luz e Imagem, Portugal

Event participation

	Activity description Type of event	Event name Institution / Organization
2025/03/06 - 2025/03/08	21º Congresso Português de Diabetes	Sociedade Portuguesa de Diabetologia, Portugal
2024/12/05 - 2024/12/05	Investigação clínica: oportunidades do novo modelo colaborativo em contexto das ULS
2024/10/22 - 2024/10/22	Acção CAPACITAR: Farmácia Hospitalar e a Gestão do Medicamento Experimental	Acção CAPACITAR AICIB, Portugal
2024/04/09 - 2024/04/09	Revisão sistemática e meta-análise	Revisão sistemática e meta-análise Universidade de Coimbra Instituto de Investigação Interdisciplinar, Portugal
2024/02/21 - 2024/02/21	Acção CAPACITAR: Gestão de contratos de ensaio clínico Workshop	AICIB, Portugal
2023/10/21 - 2023/10/21	Acção CAPACITAR: Actividades de coordenação de Investigação clínica	AICIB, Portugal
2023/06/01 - 2023/06/03	33rd EAsDEC Conference 2023	Associação para a Investigação Biomédica e Inovação em Luz e Imagem, Portugal
2023/05/05 - 2023/05/05	À mesa com saúde: organized dinner commented by chefs, scientists and clinicians, which aim to address diseases and their prevention through diet.	À mesa com saúde iCBR - Coimbra Institute for Clinical and Biomedical Research, Portugal
2023 - 2023	Interaction between genetics and the adherence to the Mediterranean diet: the risk for age-related macular degeneration.	46th Macula Society Annual Meeting Macula Society, United States
2023 - 2023	Statins and genetics in the risk of progression of age-related macular degeneration	48th Macula Society Annual Meeting Macula Society, United States
2022/06/09 - 2022/06/09	Urinary Mass Spectrometry Metabolomic Profiles in Age-related Macular Degeneration (AMD)	45th Annual Macula Society Meeting Macula Society, United States
2022/05/09 - 2022/05/09	Phenotypic expression of CFH rare variants in AMD patients	The 45th Annual Macula Society Meeting Macula Society, United States
2020/10/24 - 2020/10/24	15th EVICR.net Members Meeting 2020	15th EVICR.net Members Meeting 2020 European Vision Institute Clinical Research Network , Portugal
2020/10/02 - 2020/10/04	EURETINA 2020	EURETINA 2020 EURETINA - The European Society of Retina Specialists, Ireland
2020/07/10 - 2020/07/10	Workshop em Boas Práticas Clínicas	Workshop em Boas Práticas Clínicas Associação para a Investigação Biomédica e Inovação em Luz e Imagem, Portugal
2019/10/24 - 2019/10/25	14th EVICR.net Meeting	EVICR Network, Portugal
2019/06/12 - 2019/06/12	Clinical Research at a glance	Clinical Research at a glance iCBR - Coimbra Institute for Clinical and Biomedical Research, Portugal
2019 - 2019	Human Plasma Metabolomics in Age-related Macular Degeneration – Meta-Analysis of Two Distinct Cohorts	42nd Annual Macula Society Meeting Macula Society, United States
2017/04/07 - 2017/04/07	Ciclo de Divulgação: Update on OCT Angiography	Associação para a Investigação Biomédica e Inovação em Luz e Imagem, Portugal
2016/12/05 - 2016/12/05	Lançamento do Registo Nacional de Estudos Clínicos	Infarmed Autoridade Nacional do Medicamento e Produtos de Saúde IP, Portugal
2016/11/09 - 2016/11/09	Ciclo de Conferências "Saber investir, saber inovar. Inovação clínica - do compromisso à acção"	Associação Portuguesa da Indústria Farmacêutica, Portugal
2016/11/04 - 2016/11/04	II Encontro Regional de Farmacovigilância	Associação para a Investigação Biomédica e Inovação em Luz e Imagem, Portugal
2016/02/13 - 2016/02/13	Reunião Científica do GER (Grupo de Estudos da Retina)	Sociedade Portuguesa de Oftalmologia, Portugal
2015/11/26 - 2015/11/27	10th EVICR.net Members Meeting	EVICR Network, Portugal
2014/11/16 - 2014/11/18	9th EVICR.net Members Meeting	EVICR Network, Portugal

Jury of academic degree

	Topic Role	Candidate name (Type of degree) Institution / Organization
2024/09/30	Fragilidade de ensaios clínicos com Nirmatrelvir-Ritonavir (Paxlovid) em doentes com COVID -19 não hospitalizados: revisão sistemática (Thesis) Main arguer	Raquel Duarte Gomes (Master) Universidade de Coimbra Faculdade de Farmácia, Portugal

Association member

	Society Organization name	Role
2024 - Current	Member of the Group of Interest in Clinical Trials of the Portuguese Pharmaceutical Board	Member
2023 - Current	EURETINA - European Society of Retina Specialists	Member
2005/08 - Current	Portuguese Pharmaceutical Board (Ordem dos Farmacêuticos)	Member

Course / Discipline taught

	Academic session	Degree Subject (Type)	Institution / Organization
2025/04/08 - 2025/04/08	O que faz um farmacêutico num ensaio clínico	Ciências Farmacêuticas (Licenciatura)	Universidade de Coimbra Faculdade de Farmácia, Portugal
2024/12/02 - 2024/12/10	Fundamentals of Clinical Research and Clinical Trials	Ortóptica (Licenciatura)	Instituto Politécnico do Porto, Portugal
2024/10/25 - 2024/10/25	Fundamentals of Clinical Research	Farmacologia Aplicada (Mestrado)	Universidade de Coimbra Faculdade de Farmácia, Portugal
2024/10/23 - 2024/10/23	Fundamentals of Clinical Research	Mestrado em Investigação Biomédica (Mestrado)	Universidade de Coimbra Faculdade de Medicina, Portugal
2024/03/14 - 2024/03/14	Ensaio Clínico	Ortóptica (Licenciatura)	Instituto Politécnico do Porto Escola Superior de Saúde, Portugal
2023/11/03 - 2023/11/03	Fundamentals of Clinical Research	Farmacologia Aplicada (Mestrado integrado)	Universidade de Coimbra Faculdade de Farmácia, Portugal
2023/10/31 - 2023/10/31	Fundamentals of Clinical Research	Mestrado em Investigação Clínica (Mestrado)	Universidade de Coimbra Faculdade de Medicina, Portugal
2023/03/15 - 2023/03/22	Processo de Ensaio Clínico	Ortóptica (Licenciatura)	Instituto Politécnico do Porto Escola Superior de Saúde, Portugal
2022/10/18 - 2022/10/18	Clinical Research	Mestrado em Investigação Biomédica (Mestrado)	Universidade de Coimbra Faculdade de Medicina, Portugal
2022/03/23 - 2022/03/30	Processo de Ensaio Clínico	Ortóptica (Licenciatura)	Instituto Politécnico do Porto Escola Superior de Saúde, Portugal
2022/03/14 - 2022/03/14	Ensaios Clínicos	Ortóptica (Licenciatura)	Instituto Politécnico do Porto Escola Superior de Saúde, Portugal
2022 - 2022	Building a study protocol: rationale, hypothesis, design, significant sample calculation	Curso de Investigação Clínica para Oftalmologistas (Outros)	Sociedade Portuguesa de Oftalmologia, Portugal
2020/10/28 - 2020/10/28	Workshop on clinical research	Mestrado em Investigação Biomédica (Mestrado)	Universidade de Coimbra Faculdade de Medicina, Portugal
2019/10/28 - 2019/10/28	Fundamentals on Clinical Research	Mestrado em Investigação Biomédica (Mestrado)	Universidade de Coimbra Faculdade de Medicina, Portugal
2019/05/31 - 2019/05/31	Seminário/ Investigação Translacional em Oftalmologia.	Ortóptica (Licenciatura)	Instituto Politécnico do Porto Escola Superior de Saúde, Portugal
2019/03/25 - 2019/03/25	Clinical Research no âmbito da Unidade Curricular de Desenvolvimento Farmacêutico, Licenciatura em Ciências Biomédicas	Biomedicina Farmacêutica (Licenciatura)	Universidade de Aveiro Departamento de Ciências Médicas, Portugal
2018/03/16 - 2018/03/16	Seminário - Investigação Translacional em Oftalmologia.	Ortóptica (Licenciatura)	Instituto Politécnico do Porto Escola Superior de Saúde, Portugal
2016/05/21 - 2016/05/21	Investigação Clínica – a perspetiva do Investigador e contextualização legal.	Ortóptica (Licenciatura)	Instituto Politécnico do Porto Escola Superior de Saúde, Portugal

Distinctions

Award

2024	Prémio Plácido Sociedade Portuguesa de Oftalmologia, Portugal
2023	Prémio Plácido Sociedade Portuguesa de Oftalmologia, Portugal
2022	Prémio Plácido
2022	Melhor Artigo de Retina Sociedade Portuguesa de Oftalmologia, Portugal
2021	Prémio Plácido Sociedade Portuguesa de Oftalmologia, Portugal
2021	Prémio de Melhor Poster de Investigação Clínica Sociedade Portuguesa de Diabetologia, Portugal